BREAKING
Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 hour ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 11 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 13 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 14 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 1 hour ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 3 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 5 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 7 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 9 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 10 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 11 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 11 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 13 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 14 hours ago
ADVERTISEMENT
AlphaGraphs

AngioDynamics second-quarter results beat market estimates

AngioDynamics posted second-quarter earnings on Friday, Jan. 4. before trading hours. Net sales for the period inched 5.5% to $91.5 million, with diluted net profit jumping to $0.06 per share — growing six-fold from last year’s $0.01 per share. Net income soared to $2.14 million, up from $249,000. The market expected earnings of $0.20 per share on […]

January 4, 2019 2 min read

AngioDynamics posted second-quarter earnings on Friday, Jan. 4. before trading hours. Net sales for the period inched 5.5% to $91.5 million, with diluted net profit jumping to $0.06 per share — growing six-fold from last year’s $0.01 per share. Net income soared to $2.14 million, up from $249,000.

The market expected earnings of $0.20 per share on revenue of $88.90 million. Both top line and bottom line exceeded the consensus.

Gross margin for the quarter soared 440 basis points year over year to 53.7%, while cash provided by operations was $13.0 million. Capital expenditures was $0.7 million for the period.

US net sales in the quarter rose 5.2% to $71.9 million while International net sales grow 6.6% to $19.6 million.

AngioDynamics second quarter 2019 Earnings Infographic

ADVERTISEMENT

Back in September, AngioDynamics announced that it would acquire privately held medical diagnostic and device company RadiaDyne. The latter designs and develops patient dose monitoring technology to improve cancer treatment outcomes.

This deal added to AngioDynamics’ portfolio RadiaDyne’s early-stage, proprietary real-time radiation dose monitoring platform and other market-leading oncology solutions.

“The acquisition of RadiaDyne, combined with our recent BioSentry asset purchase, delivers on our commitment to build a world-class oncology portfolio,” said CEO Jim Clemmer.

In September of 2018, RadiaDyne’s trailing 12-months revenues exceeded $6 million. The acquisition was then expected to be neutral to earnings on an adjusted basis.

In the previously reported first-quarter, AngioDynamics missed analyst estimates with earnings of $0.16 per share, sending shares down then. The company had reported flat revenues of $85.3 million over last year, hurt by 6% slump in oncology product sales. it also had a one-time impact in the quarter due to its transition from Acculis to Solero product line.

ADVERTISEMENT

AngioDynamics has been seeing US sales dipping in the past two quarters, despite international sales picking up. Last quarter, it even had to pay $12.7 million due to the legal allegations faced with the Justice Department.

 

 

We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

ADVERTISEMENT